Free Trial

Synairgen (SNG) Competitors

Synairgen logo
GBX 4.62 0.00 (0.00%)
(As of 11/19/2024 ET)

SNG vs. COS, SBTX, C4XD, DDDD, AREC, SAR, OKYO, OBI, AOR, and HEMO

Should you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Collagen Solutions plc (COS.L) (COS), SkinBioTherapeutics (SBTX), C4X Discovery (C4XD), 4D pharma (DDDD), Arecor Therapeutics (AREC), Sareum (SAR), OKYO Pharma (OKYO), Ondine Biomedical (OBI), AorTech International (AOR), and Hemogenyx Pharmaceuticals (HEMO). These companies are all part of the "biotechnology" industry.

Synairgen vs.

Synairgen (LON:SNG) and Collagen Solutions plc (COS.L) (LON:COS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

Collagen Solutions plc (COS.L) has higher revenue and earnings than Synairgen. Synairgen is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synairgen£79K117.77-£42.87M-£0.03-154.00
Collagen Solutions plc (COS.L)£4.01M0.00N/A-£0.80N/A

In the previous week, Synairgen's average media sentiment score of 0.00 equaled Collagen Solutions plc (COS.L)'saverage media sentiment score.

Company Overall Sentiment
Synairgen Neutral
Collagen Solutions plc (COS.L) Neutral

30.7% of Synairgen shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Synairgen's return on equity.

Company Net Margins Return on Equity Return on Assets
SynairgenN/A -48.86% -30.58%
Collagen Solutions plc (COS.L) N/A N/A N/A

Synairgen received 24 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 56.46% of users gave Synairgen an outperform vote.

CompanyUnderperformOutperform
SynairgenOutperform Votes
153
56.46%
Underperform Votes
118
43.54%
Collagen Solutions plc (COS.L)Outperform Votes
129
72.88%
Underperform Votes
48
27.12%

Summary

Collagen Solutions plc (COS.L) beats Synairgen on 5 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNG vs. The Competition

MetricSynairgenBiotechnology IndustryMedical SectorLON Exchange
Market Cap£9.30M£181.60M£4.98B£1.14B
Dividend Yield1.53%3.54%7.77%11.45%
P/E Ratio-149.63186.7384.831,595.27
Price / Sales117.7717,456.521,387.25228,485.71
Price / Cash1.9011.4333.4033.63
Price / Book0.187.484.672.84
Net Income-£42.87M-£19.46M£115.27M£146.23M
7 Day Performance8.45%7.53%-2.96%4.19%
1 Month Performance-3.55%9.89%-4.00%2.69%
1 Year Performance-30.53%29.56%30.36%126.35%

Synairgen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNG
Synairgen
N/AGBX 4.62
flat
N/A-32.8%£9.30M£79,000.00-149.6334
COS
Collagen Solutions plc (COS.L)
N/AGBX 6.63
flat
N/A+0.0%£30.99M£4.01M-8.283,350
SBTX
SkinBioTherapeutics
N/AGBX 13.50
-1.8%
N/A-30.5%£30.52M£21,949.00-675.0011News Coverage
C4XD
C4X Discovery
N/AGBX 12
+27.3%
N/A-3.8%£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AGBX 16.66
flat
N/AN/A£30.05M£718,000.00-1.08106
AREC
Arecor Therapeutics
N/AGBX 76
flat
N/A-58.8%£28.70M£4.90M-271.4310News Coverage
SAR
Sareum
N/AGBX 24.85
+1.4%
N/A-60.8%£26.83M£47,204.00-414.173,211
OKYO
OKYO Pharma
N/AGBX 1.40
-24.3%
N/AN/A£23.24MN/A-140.007Gap Down
OBI
Ondine Biomedical
N/AGBX 8.13
+1.6%
N/A-10.7%£22.53M£1.63M-270.83N/AGap Up
AOR
AorTech International
N/AGBX 123.50
-2.4%
N/A+0.0%£19.99M£539,000.00-33.383
HEMO
Hemogenyx Pharmaceuticals
N/AGBX 1.09
+3.6%
N/A-45.6%£14.57MN/A-108.7014Gap Down

Related Companies and Tools


This page (LON:SNG) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners